6,7-Dimethoxy-4-hydroxyquinoline (CAS No: 13425-93-9) is a key pharmaceutical intermediate used in the synthesis of APIs Cabozantinib and Tivozanib. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: 4(1H)-Quinolinone, 6,7-dimethoxy-;, 4-Quinolinol, 6,7-dimethoxy-
CAS No: 13425-93-9
PubChem CID: 459611
Mol Formula: C11H11NO3
Mol Weight: 205.21 g/mol
Used in APIs: Cabozantinib and Tivozanib
IUPAC Name: 6,7-dimethoxy-1H-quinolin-4-one
API Intermediate Description: 6,7-Dimethoxy-4-hydroxyquinoline (also known as 4-hydroxy-6,7-dimethoxyquinoline) is primarily used as a crucial chemical intermediate in synthesizing important pharmaceuticals, especially cancer drugs like Cabozantinib and Tivozanib, by converting it to 4-chloro-6,7-dimethoxyquinoline. Beyond oncology, its uses extend to exploring treatments for neurodegenerative disorders, developing antimalarial agents, serving as a research tool in neurobiology, and even having potential in cosmetics for antioxidant properties or material science, though its main industrial role is as a versatile building block.
